A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection

PLoS Neglected Tropical Diseases

Volumn 4, Issue 3, 2010, Pages

  Aronson, Naomi E ^a,b   Wortmann, Glenn W ^a,b   Byrne, William R ^b   Howard, Robin S ^b   Bernstein, Wendy B ^a,c   Marovich, Mary A ^a,c   Polhemus, Mark E ^a,b   Yoon, In Kyu ^c   Hummer, Kelly A ^b,d   Gasser Jr , Robert A ^a,b   Oster, Charles N ^a,b   Benson, Paul M ^b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d Clinical Research Management   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; STIBOGLUCONATE SODIUM; ANTIMONY GLUCONATE;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLISTER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CREATINE KINASE BLOOD LEVEL; CYTOPENIA; DIARRHEA; DIZZINESS; DRUG EFFICACY; DYSPNEA; EPITHELIZATION; ERYTHEMA; FATIGUE; FEMALE; FEVER; FOLLOW UP; HEADACHE; HUMAN; HYPERTHERMIC THERAPY; KELOID; LEISHMANIA MAJOR; LEISHMANIASIS; MAJOR CLINICAL STUDY; MALE; MICROBIAL IDENTIFICATION; MYALGIA; NAUSEA; NONHUMAN; OUTCOME ASSESSMENT; PANCREATITIS; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SKIN BIOPSY; SKIN INFECTION; THORAX PAIN; TREATMENT DURATION; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; VOMITING; WOUND HEALING; WOUND INFECTION; ADOLESCENT; ADULT; ANIMAL; DRUG EFFECT; DRUG TOXICITY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; RADIATION EXPOSURE; SKIN LEISHMANIASIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANIMALS; ANTIMONY SODIUM GLUCONATE; DRUG TOXICITY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INJECTIONS, INTRAVENOUS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950409905     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000628     Document Type: Article

References (27)

1. World Health Organization. Leishmaniasis: Burden of disease magnitude. Available: http://www.who.int/leishmaniasis/burden/magnitude/burden-magnitude/ en/print.html. Accessed January 25, 2009.
2. Medical Surveillance Monthly Report (MSMR) (2007) Armed Forces Health Surveillance Center 14(1): 2-5. Available: http://amsa.army.mil/msmr.htm. Accessed 23 May 2009.
3. Aronson NE, Wortmann GW, Johnson SC, Jackson JE, Gasser RA, et al. (1998) Safety and efficacy of intravenous Sodium Stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin Infect Dis 27(6): 1457-1464.
4. Berman JD, Neva FA (1981) Effect of temperature on multiplication of Leishmania amastigotes within human monocyte-derived macrophages in vitro. Am J Trop Med Hyg 30(2): 318-321.
5. Sacks DL, Barral A, Neva FA (1983) Thermosensitivity patterns of old vs. new world cutaneous strains of Leishmania growing with mouse peritoneal macrophages in vitro. Am J Trop Med Hyg 32(2): 300-304.
6. Kirkpatrick CE, Nolan TJ, Farrell JP (1987) Rate of Leishmania-induced skin-lesion development in rodents depends on the site of inoculation. Parasitology 94(3): 451-465.
7. Aragort De Rossell R, Rossell O, De Jesús De Durán R, Rodríguez AM (1993) Thermotherapy v. antimonials: what happens after the healing of cutaneous leishmaniasis lesions? Ann Trop Med Parasitol 87(1): 23-30.
8. Mutinga MJ, Mugola EN (1974) Alternate treatment of cutaneous leishmaniasis. East Afr Med J 51: 68-78.
9. Neva FA, Petersen EA, Corsey R, Bogaert BD, Martinez D (1984) Observations on local heat treatment for cutaneous leishmaniasis. Am J Trop Med Hyg 33(5): 800-804.
10. Junaid AJ (1986) Treatment of cutaneous leishmaniasis with infrared heat. Int J Dermatol 25(7): 470-472.
11. Aram H, Leibovici V (1987) Ultrasound-induced hyperthermia in the treatment of cutaneous leishmaniasis. Cutis 40(4): 350-353.
12. Navin TR, Arana BA, Arana FE, De Merida AM, Castillo AL, et al. (1990) Placebo-controlled clinical trial of Meglumine Antimoniate (Glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala. Am J Trop Med Hyg 42(1): 43-50.
13. Levine N (1992) Cutaneous leishmaniasis treated with controlled localized heating. Arch Dermatol 128(6): 759-761.
14. Velasco-Castrejon O, Walton BC, Rivas-Sanchez B, Garcia ME, Lazaro GJ, et al. (1997) Treatment of cutaneous leishmaniasis with localized current field (radio frequency) in Tabasco, Mexico. Am J Trop Med Hyg 57(3): 31-34.
15. Lobo IM, Soares MB, Correia TM, de Freitas L, Oliveira MI, et al. (2006) Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapy. Trans R Soc Trop Med Hyg 100(7): 642-649.
16. Willard RJ, Jeffcoat AM, Benson PM, Walsh DS (2005) Cutaneous leishmaniasis in soldiers from Fort Campbell, Kentucky returning from Operation Iraqi Freedom highlights diagnostic and therapeutic options. J Am Acad Dermatol 52(6): 977-987.
17. Reithinger R, Mohsen M, Wahid M, Bismullah M, Quinnell RJ, et al. (2005) Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis 40(8): 1148-1154
18. Sadeghian G, Nilfroushzadeh MA, Iraji F (2007) Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate. Clin Exp Dermatol 32(4): 371-374.
19. Vega JC, Sanchez BF, Montero LM, Montana R, Del Pilar Mahecha M, et al. (2009) The efficacy of thermotherapy to treat cutaneous leishmaniasis in Colombia: a comparative observational study in an operational setting. Trans R Soc Trop Med Hyg 103(7): 703-706.
20. Wortmann G, Miller RS, Oster C, Jackson J, Aronson N (2002) A randomized, double-blind study of the efficacy of a 10 or 20 day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in U.S. military personnel. Clin Infect Dis 35: 261-267.
21. Wortmann G, Hochberg L, Houng HH, Sweeney C, Zapor M, et al. (2005) Rapid identification of Leishmania complexes by a real-time PCR assay. Am J Trop Med Hyg 73(6): 999-1004.
22. Gonzalez U, Pinart M, Reveiz L, Alvar J (2009) Interventions for old world cutaneous leishmaniasis (Review). Cochrane Database Syst Rev 15(2): CD 005067.
23. Kim DH, Chung HJ, Bleys J, Ghohestani R (2009) Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials. PLOS Negl Trop Dis 3(2): e381.
24. Reithinger R, Coleman P (2007) Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting. BMC Infect Dis 7: 3.
25. Vega J, Sanchez B, Montero L, Montana R, Del Pilar Mahecha M, et al. (2007) Short communication: The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004. Trop Med Int Health 12(12): 1540-1544.
26. Mendonca M, De Brito M, Rodriguez E, Bandeira V, Jardim M, et al. (2004) Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leshmaniasis: Is there a sterile cure? J Infect Dis 189: 1018-1023.
27. Okwor I, Vzonna J (2008) Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies. Immunol Res 41: 123-136.